In line with longitudinal studies in preclinical AD and autosomal dominant AD, showing that amyloid pathology is present years before tau pathology and symptoms onset [59, 60], our study in the cognitively normal midlife population showed no association of obesity, abdominal fat metrics, or insulin resistance with brain tau uptake. The gene discussed is MAPT; the disease is obesity disorder.